Guillain-Barré Syndrome : Oregon Health News Blog

Hay un pequeño riesgo de desarrollar el síndrome de Guillain-Barré (GBS) asociado con la vacuna de la compañía Johnson & Johnson

Posted on July 13, 2021 by ohacovidblogger

El día de hoy, los Centros para el Control y la Prevención de Enfermedades (CDC) informaron que los datos del Sistema de Notificación de Eventos Adversos de Vacunas (VAERS) de EE. UU. muestran un pequeño riesgo de desarrollar el síndrome de Guillain-Barré (GBS) después de recibir la vacuna contra el COVID-19 de la compañía Johnson […]

Small risk of Guillain-Barré Syndrome (GBS) associated with Johnson & Johnson vaccine

Posted on July 12, 2021December 9, 2021 by ohacovidblogger

Today, the Centers for Disease Control and Prevention (CDC) reported that reports to the U.S. Vaccine Adverse Events Reporting System (VAERS) indicate a small risk of Guillain-Barré Syndrome (GBS) following receipt of the Johnson & Johnson (J&J) COVID-19 vaccine. About 100 preliminary reports of GBS have been filed with VAERS after the administration of 12.8 million doses of the J&J vaccine. The cases were largely […]